Todd Franklin Watanabe - 02 Nov 2026 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

SEC form
4
Accepted by SEC
04 Nov 2026, 18:38:31 UTC
Prior SEC filing
05 Aug 2026
Source filing
View source filing
Filing notes and source

Key filing fact

Todd Franklin Watanabe filed Form 4 for Arcutis Biotherapeutics, Inc. (ARQT) on 04 Nov 2026.

Key facts

  • This page summarizes Todd Franklin Watanabe's Form 4 filing for Arcutis Biotherapeutics, Inc. (ARQT).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 04 Nov 2026, 18:38.

Change

  • Previous filing in this sequence was filed on 05 Aug 2026.
  • Current net transaction value: -$139,466.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001801061 Primary reporting owner

Watanabe Todd

Relationship
Reporting Person's title: President and Chief Executive Officer, Director

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ARQT transaction

Common Stock

Sale

Transaction value
-$139,466
Shares
-4,377
Change %
-0.61%
Price
$31.86
Shares after
712,826
Date
02 Nov 2026
Ownership
Direct
Footnotes
F1, F2
ARQT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
25,410
Date
02 Nov 2026
Ownership
By Trust
Footnotes
F3
ARQT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
25,410
Date
02 Nov 2026
Ownership
By Trust
Footnotes
F4
ARQT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
57,358
Date
02 Nov 2026
Ownership
By LLC
Footnotes
F5
ARQT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
124,956
Date
02 Nov 2026
Ownership
By Trust
Footnotes
F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units.

Footnote F2

The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $31.57 to $32.23, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Footnote F3

The securities are held of record by The John Franklin Watanabe Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.

Footnote F4

The securities are held of record by The Anderson Prest Watanabe Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.

Footnote F5

The securities are held of record by Watanabe Ventures, LLC, of which the Reporting Person is the Chief Operating Officer. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.

Footnote F6

The securities are held of record by The Watanabe 2016 Irrevocable Trust, of which the Reporting Person's children are beneficiaries. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.

SEC remarks

Reporting Person's title: President and Chief Executive Officer

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .